Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
104364201000001118 | Memantine 20mg soluble tablets sugar free (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
104364301000001110 | Memantine 20mg soluble tablets sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Memantine 20mg soluble tablets sugar free (Zentiva Pharma UK Ltd) | Is a | True | Memantine 20mg soluble tablets sugar free | Inferred relationship | Existential restriction modifier | |
Alzhok 20mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) | Is a | True | Memantine 20mg soluble tablets sugar free | Inferred relationship | Existential restriction modifier | |
Memantine 20mg soluble tablets sugar free 28 tablet | Has VMP | True | Memantine 20mg soluble tablets sugar free | Inferred relationship | Existential restriction modifier | |
Memantine 20mg soluble tablets sugar free 7 tablet | Has VMP | True | Memantine 20mg soluble tablets sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets